Due to publication bias related to small studies that tended to exaggerate the true effect [65], as well as limited number of studies that could compare CagA between the risks of gastric cancer and peptic ulcer disease, a type II error may be an issue. The gene discussed is S100A8; the disease is gastric cancer.